- Daily News for Senior Citizens

  FRONT PAGE • Aging • Health • Alzheimer's - Mental • Nutrition • Medicare & Medicaid • Politics  • Fitness  • Social Security • Alerts • Sex Health • Features • Retirement • Elder Care  >Search  >Senior Links

Senior Journal: Today's News and Information for Senior Citizens & Baby Boomers


Medicare & Medicaid News

Government Streamlining Medicare Coverage For Cancer Test

In a clinical trial, Colorguard detected 92 percent of colorectal cancers and 42 percent of advanced adenomas, large polyps that are more likely than small polyps to lead to cancer.

By Michelle Andrews, Insuring Your Health

More From This Series Insuring Your Health

Aug. 19, 2014 - Medicare beneficiaries may get speedier coverage for a newly approved screening test for colorectal cancer under a pilot project in which two federal agencies reviewed the product at the same time instead of one after the other.

The Cologuard test, which detects the presence of DNA mutations that may be cancers in the stool, was approved by the Food and Drug Administration this week. The same day, the Centers for Medicare& Medicaid Services issued a proposal to cover the test once every three years in asymptomatic people over age 50 who are at average risk for the disease.

It’s the first time the agencies have undertaken a parallel review, and it could trim up to six months off the time it takes to offer Medicare coverage for a medical device, according to Nancy Stade, deputy director for policy at the FDA’s Center for Devices and Radiological Health in the FDA news release.

Although CMS has proposed covering the test, a final decision won’t be made until after a 30-day comment period.

Advocates say parallel review could be good for patients. "The American Cancer Society Cancer Action Network is in support of the parallel review process as it has the potential to accelerate access to evidence-based tests," says Mona Shah, associate director of  federal affairs for the group. The organization, however, hasn’t taken a position on the new test yet.

If Medicare covers the test, private insurers will generally follow suit, say experts. The new test will reportedly cost between $500 and $600.


Related Archive Stories


FDA Approves First Non-Invasive DNA Screening Test for Colorectal Cancer

Collaboration with Centers for Medicare & Medicaid Services contributed to proposed Medicare coverage for Cologuard

Aug. 19, 2014

Read the latest news
> Medicare/Medicaid
> Senior Politics
Today's Headlines


The U.S. Preventive Services Task Force, which under the health law determines which preventive treatments should be covered by private health plans without cost sharing, said in 2008 there was not enough evidence to recommend DNA screening for colorectal cancer at that time. Some advocates expect the task force to re-evaluate its recommendation in the near future.

In a clinical trial, Colorguard detected 92 percent of colorectal cancers and 42 percent of advanced adenomas, large polyps that are more likely than small polyps to lead to cancer. A traditional (fecal occult) stool test was less accurate, detecting 74 percent of cancers and 24 percent of advanced adenomas. A consumer using Cologuard would receive a kit from the manufacturer, collect a stool sample at home and mail it in the kit to the Cologuard maker. If a Cologuard test comes back positive, patients are advised get a diagnostic colonoscopy.

So why not just get a colonoscopy in the first place? Even though it’s a lot more expensive than a stool test, a screening colonoscopy it will generally by covered without cost sharing by Medicare and private insurers.

“A lot of [asymptomatic] people won’t get a colonoscopy, and this is an effective, less invasive screening method,” says Eric Hargis, CEO of the Colon Cancer Alliance. “We believe the best method is the one that gets used.”

Please contact Kaiser Health News to send comments or ideas for future topics for the Insuring Your Health column.

This article was produced by Kaiser Health News with support from The SCAN Foundation.

This KHN story, originally published Aug 15, 2014, can be republished for free. (details)

Some of this information is reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

Follow on  and 


Financial Relief for Volkswagen Diesel Owners

You may be eligible for money damages if you owned or leased one of these VW, Porsche or Audi vehicles.

In the major scandal of 2015, Volkswagen cheated you and the world. They rigged diesel emission controls so you, nor regulators, would know how much pollution their cars were adding to our environment.

They were caught and have reserved $7.3 billion to help "make it right" with victims.

If you owned or leased one of these vehicles, contact us now.

 Beth Janicek, Board Certified Personal Injury Attorney Janicek Law attorneys are actively pursuing these cases against VW. Do Not Wait...

Janicek Law Firm, PC

Free Consultation

(Call toll free)

1-877-795-3425 or Email

Vehicles Involved

VW Jetta (2009–2015)

VW Jetta SportWagen (2009–2014)

VW Golf (2010-2015)

VW Golf SportWagen (2015)

VW Beetle (2012–2015)

VW Passat (2012-2015)

Audi A3 (2010-2015)

VW Touareg (2009–2016)

Porsche Cayenne (2015)

Audi A6, A7, A8, Q5 Quattro (2016)


Search for more about this topic on

Google Web

Keep up with the latest news for senior citizens, baby boomers


Click to More Senior News on the Front Page






Published by New Tech Media -

Other New Tech Media sites include,,,, etc.